← Back to Search

Speech-in-Noise Treatment Program for Parkinson's Disease

Phase 2
Waitlist Available
Led By Scott Adams
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days
Awards & highlights

Study Summary

This trial will test two new treatments for hypophonia, or reduced speech intensity, in Parkinson's disease. The treatments focus on improving speech intensity during conversations in different social contexts and a wide range of background noise conditions.

Eligible Conditions
  • Parkinson's Disease
  • Speech Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
speech-to-noise ratio
Secondary outcome measures
communication effectiveness ratings
communication participation ratings

Trial Design

3Treatment groups
Active Control
Group I: Speech-in-Noise Treatment ProgramActive Control1 Intervention
A behavioural speech therapy program involving 12, one-hour treatment sessions over a 4-week period
Group II: Speech-to-Noise Feedback Device ProgramActive Control1 Intervention
A speech treatment program involving the use of a speech-to-noise feedback device during 12, one-hour treatment sessions over a 4-week period
Group III: Delayed TreatmentActive Control1 Intervention
Assessments but no intervention for a period of 13 weeks.

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor
659 Previous Clinical Trials
413,652 Total Patients Enrolled
Scott AdamsPrincipal InvestigatorWestern University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Speech-in-Noise Treatments for Hypophonia in Parkinson's Disease
Scott Adams 2020. "Speech-in-Noise Treatments for Hypophonia in Parkinson's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04323085.
~17 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top